Skip to main content
Top
Published in: Journal of Radiation Oncology 3-4/2020

01-12-2020 | Computed Tomography | Original Research

Feasibility of simulation contrast-enhanced computed tomography (CECTSim) of the head and neck region to detect early nodal recurrence in postoperative oral squamous cell carcinoma in a resource-constrained setup

Authors: Ramaiah Vinay Kumar, Sabitha K S, Samruddhi Sanjay Pujalwar, Suman Bhasker

Published in: Journal of Radiation Oncology | Issue 3-4/2020

Login to get access

Abstract

Background

Early postoperative nodal recurrence (EPNR) of oral squamous cell carcinoma (OSCC) is not uncommon. Such recurrences may change the intent of treatment and/or volumes of radiotherapy. Contrast-enhanced computed tomography (CECT), magnetic resonance imaging (MRI), and positron emission tomography (PET) have a similar ability to detect lymph node metastasis. However, obtaining postoperative imaging for detecting early recurrence and the initiation of postoperative radiotherapy (PORT) are competing priorities. Hence, we assessed the feasibility of simulation computed tomography (CTSim) for the detection of EPNR in OSCC.

Methods

CECTSim of 5-mm slice thickness with thermoplastic immobilization was performed in 21 consecutive postoperative patients with OSCC. Treating radiation oncologists and trained radiologists used CECTSim to screen and evaluate the presence of early regional lymph node recurrence.

Results

Six out of twenty-one consecutive postoperative OSCC patients had radiological evidence of EPNR on CECTSim. Except for one patient, all EPNRs were limited to contralateral level 1–3 regional nodes in this small series of postoperative OSCC patients. The detection of EPNR on CECTSim necessitated a change in the radiation treatment volume and the corresponding prescribed dose to the target volume.

Conclusion

CECTSim may be helpful in the detection of EPNR in OSCC and may preclude the need for additional imaging before the start of PORT. CECTSim may also facilitate the appropriate determination of the radiation volume and appropriate dose to the corresponding target volume.
Literature
1.
go back to reference Hosni A, Huang SH, Chiu K, Xu W, Su J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O’Sullivan B, Ringash J, Waldron J, Spreafico A, Yu E, de Almeida JR, Monteiro E, Chepeha DB, Irish JC, Goldstein DP, Hope A (2019) Predictors of early recurrence prior to planned postoperative radiation therapy for oral cavity squamous cell carcinoma and outcomes following salvage intensified radiation therapy. Int J Radiat Oncol Biol Phys 103(2):363–373CrossRef Hosni A, Huang SH, Chiu K, Xu W, Su J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O’Sullivan B, Ringash J, Waldron J, Spreafico A, Yu E, de Almeida JR, Monteiro E, Chepeha DB, Irish JC, Goldstein DP, Hope A (2019) Predictors of early recurrence prior to planned postoperative radiation therapy for oral cavity squamous cell carcinoma and outcomes following salvage intensified radiation therapy. Int J Radiat Oncol Biol Phys 103(2):363–373CrossRef
2.
go back to reference Kumar RV, Bhasker S (2017) A peek into epidemiology, screening, management of breast cancer in developing countries: experience from two regional cancer centers in India. Breast J 5:422–423 Kumar RV, Bhasker S (2017) A peek into epidemiology, screening, management of breast cancer in developing countries: experience from two regional cancer centers in India. Breast J 5:422–423
3.
go back to reference Joo Y-H, Cho J-K, Koo BS, Kwon M, Kwon SK, Kwon SY, Kim MS, Kim JK, Kim H, Nam I, Roh JL, Park YM, Park IS, Park JJ, Shin SC, Ahn SH, Won S, Ryu CH, Yoon TM, Lee G, Lee DY, Lee MC, Lee JK, Lee JC, Lim JY, Chang JW, Jang JY, Chung MK, Jung YS, Cho JG, Choi YS, Choi JS, Lee GH, Chung PS (2019 May) Guidelines for the surgical management of oral cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol 12(2):107–144CrossRef Joo Y-H, Cho J-K, Koo BS, Kwon M, Kwon SK, Kwon SY, Kim MS, Kim JK, Kim H, Nam I, Roh JL, Park YM, Park IS, Park JJ, Shin SC, Ahn SH, Won S, Ryu CH, Yoon TM, Lee G, Lee DY, Lee MC, Lee JK, Lee JC, Lim JY, Chang JW, Jang JY, Chung MK, Jung YS, Cho JG, Choi YS, Choi JS, Lee GH, Chung PS (2019 May) Guidelines for the surgical management of oral cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol 12(2):107–144CrossRef
4.
go back to reference Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA et al (2014) Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. RadiotherOncol 110(1):172–181 Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA et al (2014) Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. RadiotherOncol 110(1):172–181
5.
go back to reference Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A et al (2018) Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. RadiotherOncol 126(1):3–24 Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A et al (2018) Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. RadiotherOncol 126(1):3–24
6.
go back to reference Merlotti A, Alterio D, Vigna-Taglianti R, Muraglia A, Lastrucci L, Manzo R, Gambaro G, Caspiani O, Miccichè F, Deodato F, Pergolizzi S, Franco P, Corvò R, Russi EG, Sanguineti G, Italian Association of Radiation Oncology (2014 Dec 29) Technical guidelines for head and neck cancer IMRT on behalf of the Italian Association of Radiation Oncology – head and neck working group. Radiat Oncol 9:264CrossRef Merlotti A, Alterio D, Vigna-Taglianti R, Muraglia A, Lastrucci L, Manzo R, Gambaro G, Caspiani O, Miccichè F, Deodato F, Pergolizzi S, Franco P, Corvò R, Russi EG, Sanguineti G, Italian Association of Radiation Oncology (2014 Dec 29) Technical guidelines for head and neck cancer IMRT on behalf of the Italian Association of Radiation Oncology – head and neck working group. Radiat Oncol 9:264CrossRef
7.
go back to reference Vorwerk H, Hess CF (2011 Aug 19) Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region. Radiat Oncol 6:97CrossRef Vorwerk H, Hess CF (2011 Aug 19) Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region. Radiat Oncol 6:97CrossRef
8.
go back to reference Lindberg RD (1977) Squamous cell carcinoma of the oral cavity and oropharynx. Ear Nose Throat J 56(3):102–109PubMed Lindberg RD (1977) Squamous cell carcinoma of the oral cavity and oropharynx. Ear Nose Throat J 56(3):102–109PubMed
9.
go back to reference Meoz RT, Fletcher GH, Lindberg RD (1982 Nov) Anatomical coverage in elective irradiation of the neck for squamous cell carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 8(11):1881–1885CrossRef Meoz RT, Fletcher GH, Lindberg RD (1982 Nov) Anatomical coverage in elective irradiation of the neck for squamous cell carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 8(11):1881–1885CrossRef
10.
go back to reference Brandwein–Gensler M, Smith RV, Wang B et al (2010) Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol 34:676–688CrossRef Brandwein–Gensler M, Smith RV, Wang B et al (2010) Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol 34:676–688CrossRef
11.
go back to reference Liu SA, Wang CC, Jiang RS, Lee FY, Lin WJ, Lin JC (2017) Pathological features and their prognostic impacts on oral cavity cancer patients among different subsites - a single institute’s experience in Taiwan. Sci Rep 7(1):7451CrossRef Liu SA, Wang CC, Jiang RS, Lee FY, Lin WJ, Lin JC (2017) Pathological features and their prognostic impacts on oral cavity cancer patients among different subsites - a single institute’s experience in Taiwan. Sci Rep 7(1):7451CrossRef
12.
go back to reference Lea J, Bachar G, Sawka AM, Lakra DC, Gilbert RW, Irish JC et al (2010) Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Head Neck 32:184–190PubMed Lea J, Bachar G, Sawka AM, Lakra DC, Gilbert RW, Irish JC et al (2010) Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Head Neck 32:184–190PubMed
13.
go back to reference Fan S, Tang QL, Lin YJ, Chen WL, Li JS, Huang ZQ, Yang ZH, Wang YY, Zhang DM, Wang HJ, Dias-Ribeiro E, Cai Q, Wang L (2011) A review of clinical and histological parameters associated with contralateral neck metastases in oral squamous cell carcinoma. Int J Oral Sci 3:180–191CrossRef Fan S, Tang QL, Lin YJ, Chen WL, Li JS, Huang ZQ, Yang ZH, Wang YY, Zhang DM, Wang HJ, Dias-Ribeiro E, Cai Q, Wang L (2011) A review of clinical and histological parameters associated with contralateral neck metastases in oral squamous cell carcinoma. Int J Oral Sci 3:180–191CrossRef
14.
go back to reference Ho CM, Lam KH, Wei WI, Lau SK, Lam LK (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14:359–363CrossRef Ho CM, Lam KH, Wei WI, Lau SK, Lam LK (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14:359–363CrossRef
15.
go back to reference Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P (1997) Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 19(1):14–19CrossRef Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P (1997) Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 19(1):14–19CrossRef
16.
go back to reference Kapoor C, Vaidya S, Wadhwan V, Malik S (2015) Lymph node metastasis: a bearing on prognosis in squamous cell carcinoma. Indian J Cancer 52(3):417–424CrossRef Kapoor C, Vaidya S, Wadhwan V, Malik S (2015) Lymph node metastasis: a bearing on prognosis in squamous cell carcinoma. Indian J Cancer 52(3):417–424CrossRef
17.
go back to reference Okura M, Aikawa T, Sawai N, Lida S, Kogo M (2009) Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 45:908–911CrossRef Okura M, Aikawa T, Sawai N, Lida S, Kogo M (2009) Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 45:908–911CrossRef
18.
go back to reference Lin T, Tsou Y, Bau D, Tsai M (2012) Factors influencing contralateral neck metastasis in oral squamous cell carcinoma. Formos J Surg 45(3):83–87CrossRef Lin T, Tsou Y, Bau D, Tsai M (2012) Factors influencing contralateral neck metastasis in oral squamous cell carcinoma. Formos J Surg 45(3):83–87CrossRef
19.
go back to reference Chinn SB, Spector ME, Bellile EL, McHugh JB, Gernon TJ, Bradford CR, Wolf GT, Eisbruch A, Chepeha DB (2013) Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg 149:893–899CrossRef Chinn SB, Spector ME, Bellile EL, McHugh JB, Gernon TJ, Bradford CR, Wolf GT, Eisbruch A, Chepeha DB (2013) Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg 149:893–899CrossRef
20.
go back to reference Myers JN, Greenberg JS, Mo V, Roberts D (2001) Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 92:3030–3036CrossRef Myers JN, Greenberg JS, Mo V, Roberts D (2001) Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 92:3030–3036CrossRef
21.
go back to reference Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, el Naggar AK, Myers JN (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer. 97:1464–1470CrossRef Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, el Naggar AK, Myers JN (2003) Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer. 97:1464–1470CrossRef
22.
go back to reference Tohme S, Simmons RL, Tsung A (2017) Surgery for cancer: a trigger for metastases. Cancer Res 77(7):1548–1552CrossRef Tohme S, Simmons RL, Tsung A (2017) Surgery for cancer: a trigger for metastases. Cancer Res 77(7):1548–1552CrossRef
23.
go back to reference Jensen AR, Nellemann HM, Overgaard J (2007) Tumor progression in waiting time for radiotherapy in head and neck cancer. RadiotherOncol 84(1):5–10 Jensen AR, Nellemann HM, Overgaard J (2007) Tumor progression in waiting time for radiotherapy in head and neck cancer. RadiotherOncol 84(1):5–10
24.
go back to reference El-Husseiny G, Kandil A, Jamshed A, Khafaga Y, Saleem M, Allam A et al (2000 Jun) Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors. Br J Oral Maxillofac Surg 38(3):193–199CrossRef El-Husseiny G, Kandil A, Jamshed A, Khafaga Y, Saleem M, Allam A et al (2000 Jun) Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors. Br J Oral Maxillofac Surg 38(3):193–199CrossRef
25.
go back to reference Thavarool SB, Muttath G, Nayanar S, Duraisamy K, Bhat P, Shringarpure K, Nayak P, Tripathy JP, Thaddeus A, Philip S, B S (2019) Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala. India World J Surg Oncol 17(1):15CrossRef Thavarool SB, Muttath G, Nayanar S, Duraisamy K, Bhat P, Shringarpure K, Nayak P, Tripathy JP, Thaddeus A, Philip S, B S (2019) Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala. India World J Surg Oncol 17(1):15CrossRef
26.
go back to reference Khuri FR, Kim ES, Lee JJ et al (2001) The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomark Prev 10(8):823–829 Khuri FR, Kim ES, Lee JJ et al (2001) The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomark Prev 10(8):823–829
27.
go back to reference Arjun Agarwal, Cheena Garg, MS Ganesh, Sreekanth Reddy, (2020) Molecular mechanisms of tobacco induced oral and oropharyngeal cancer: Results of a tissue microarray and immunohistochemistry-based study from a tertiary cancer center in India. Indian Journal of Pathology and Microbiology 63 (1):7 Arjun Agarwal, Cheena Garg, MS Ganesh, Sreekanth Reddy, (2020) Molecular mechanisms of tobacco induced oral and oropharyngeal cancer: Results of a tissue microarray and immunohistochemistry-based study from a tertiary cancer center in India. Indian Journal of Pathology and Microbiology 63 (1):7
Metadata
Title
Feasibility of simulation contrast-enhanced computed tomography (CECTSim) of the head and neck region to detect early nodal recurrence in postoperative oral squamous cell carcinoma in a resource-constrained setup
Authors
Ramaiah Vinay Kumar
Sabitha K S
Samruddhi Sanjay Pujalwar
Suman Bhasker
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Radiation Oncology / Issue 3-4/2020
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-020-00440-0

Other articles of this Issue 3-4/2020

Journal of Radiation Oncology 3-4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine